Stock Track | Jazz Pharmaceuticals Soars 5.01% Following Positive Analyst Ratings and Price Target Increases

Stock Track

Aug 08, 2025

Jazz Pharmaceuticals PLC (JAZZ) stock is soaring 5.01% in Thursday's intraday trading session, buoyed by positive analyst ratings and price target adjustments. The pharmaceutical company's shares are gaining momentum as Wall Street analysts express confidence in its future prospects.

Deutsche Bank has adjusted its price target for Jazz Pharmaceuticals from $152 to $154, while maintaining a Buy rating on the stock. This upward revision suggests the bank's analysts see potential for further growth in JAZZ shares. Additionally, Robert W. Baird reiterated its Buy rating for the company, setting a price target of $160.00, which represents a significant premium to the current trading price.

The bullish sentiment from multiple analysts is likely driving investor optimism, contributing to today's substantial stock price increase. According to FactSet, Jazz Pharmaceuticals has an average rating of Buy among polled analysts, with a mean price target of $182.44. This consensus view indicates that Wall Street generally sees considerable upside potential for JAZZ stock, which may be encouraging investors to bid up the shares in today's trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1111198338"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111198338\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111198338?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-08 02:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111198338","market":"us","top_or_hot":-1,"title":"Stock Track | Jazz Pharmaceuticals Soars 5.01% Following Positive Analyst Ratings and Price Target Increases","media":"Stock Track","content":"<p>Jazz Pharmaceuticals PLC (JAZZ) stock is soaring 5.01% in Thursday's intraday trading session, buoyed by positive analyst ratings and price target adjustments. The pharmaceutical company's shares are gaining momentum as Wall Street analysts express confidence in its future prospects.</p>\n\n<p>Deutsche Bank has adjusted its price target for Jazz Pharmaceuticals from $152 to $154, while maintaining a Buy rating on the stock. This upward revision suggests the bank's analysts see potential for further growth in JAZZ shares. Additionally, Robert W. Baird reiterated its Buy rating for the company, setting a price target of $160.00, which represents a significant premium to the current trading price.</p>\n\n<p>The bullish sentiment from multiple analysts is likely driving investor optimism, contributing to today's substantial stock price increase. According to FactSet, Jazz Pharmaceuticals has an average rating of Buy among polled analysts, with a mean price target of $182.44. This consensus view indicates that Wall Street generally sees considerable upside potential for JAZZ stock, which may be encouraging investors to bid up the shares in today's trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Jazz Pharmaceuticals Soars 5.01% Following Positive Analyst Ratings and Price Target Increases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Jazz Pharmaceuticals Soars 5.01% Following Positive Analyst Ratings and Price Target Increases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-08 02:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jazz Pharmaceuticals PLC (JAZZ) stock is soaring 5.01% in Thursday's intraday trading session, buoyed by positive analyst ratings and price target adjustments. The pharmaceutical company's shares are gaining momentum as Wall Street analysts express confidence in its future prospects.</p>\n\n<p>Deutsche Bank has adjusted its price target for Jazz Pharmaceuticals from $152 to $154, while maintaining a Buy rating on the stock. This upward revision suggests the bank's analysts see potential for further growth in JAZZ shares. Additionally, Robert W. Baird reiterated its Buy rating for the company, setting a price target of $160.00, which represents a significant premium to the current trading price.</p>\n\n<p>The bullish sentiment from multiple analysts is likely driving investor optimism, contributing to today's substantial stock price increase. According to FactSet, Jazz Pharmaceuticals has an average rating of Buy among polled analysts, with a mean price target of $182.44. This consensus view indicates that Wall Street generally sees considerable upside potential for JAZZ stock, which may be encouraging investors to bid up the shares in today's trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JAZZ","symbol_name":"爵士制药","start_time":0,"source_url":"","article_id":"1111198338","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111198338","pubTimestamp":1754592167,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Jazz Pharmaceuticals PLC (JAZZ) stock is soaring 5.01% in Thursday's intraday trading session, buoyed by positive analyst ratings and price target adjustments. The pharmaceutical company's shares are...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JAZZ":"爵士制药"},"translate_title":"个股追踪|Jazz Pharmaceuticals在分析师积极评级和目标价上调后飙升5.01%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JAZZ":1},"content_text":"Jazz Pharmaceuticals PLC (JAZZ) stock is soaring 5.01% in Thursday's intraday trading session, buoyed by positive analyst ratings and price target adjustments. The pharmaceutical company's shares are gaining momentum as Wall Street analysts express confidence in its future prospects.\nDeutsche Bank has adjusted its price target for Jazz Pharmaceuticals from $152 to $154, while maintaining a Buy rating on the stock. This upward revision suggests the bank's analysts see potential for further growth in JAZZ shares. Additionally, Robert W. Baird reiterated its Buy rating for the company, setting a price target of $160.00, which represents a significant premium to the current trading price.\nThe bullish sentiment from multiple analysts is likely driving investor optimism, contributing to today's substantial stock price increase. According to FactSet, Jazz Pharmaceuticals has an average rating of Buy among polled analysts, with a mean price target of $182.44. This consensus view indicates that Wall Street generally sees considerable upside potential for JAZZ stock, which may be encouraging investors to bid up the shares in today's trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}